TrialAlimentary pharmacology & therapeutics2020
Long-term safety of vedolizumab for inflammatory bowel disease.
Edward V Loftus et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
109 papers cite itlatest 60 shown
this paperpooled ittrialcites it